Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolterodine ER and Tamsulosin for Urinary Stent Symptoms
NCT01741454Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Nov 2012
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tolterodine in Ureteral obstruction (UO) (4 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Ureteral Stent Symptom Questionnaire. Started Nov 2012; status: completed.
02
Drugs
tolterodine
03
Conditions
Ureteral obstruction (UO)
Beyond the preview
Go deeper on NCT01741454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01741454.